In the present study, we observed these same shifts in breast cancer survivors relative to cancer-free participants, with lower CD4+ helper T-cell levels seen after radiation exposure and higher B-cell levels seen after chemotherapy. This evidence concerns the gene CD4 and breast carcinoma.